Immunome had a revenue of 4.01M in the quarter ending Jun 30, 2025, with 37.22%. This bring the company's revenue in the last twelve months to 12.59M, Decreased 15.09%. In the fiscal year ending Dec 31, 2024, Immunome had annual revenue of 9.04M with -35.50% growth.